... human cells grown in culture. LINGO-1 is not the only target for myelin-boosting therapies. Acorda Therapeutics of Ardsley, New York, is conducting clinical trials of an antibody that binds to the cells that give rise to myelin, although its ...
http://ift.tt/1K4vbjA
No comments:
Post a Comment